Adcock Ingram Holdings | AIP - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
Aspen Pharmacare ZAR 6.41B 5.93B 2025-06
Avita Medical AUD 10.24M 1.98M 2025-12
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Life Healthcare ZAR 2.8B 1.65B 2022-12
Moderna USD 2.6B 1.46B 2025-12
Netcare ZAR 1.5B 109M 2022-12
Organon & Co USD 672M 73M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Viatris USD 1.32B 347.1M 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12